U.S. EPA (2022a). “Our Current Understanding of the Human Health and Environmental Risks of PFAS” https://www.epa.gov/pfas/our-current-understanding-human-health-and-environmental-risks-pfas (accessed January 2022).
De Silva AO, Armitage JM, Bruton TA, Dassuncao C, Heiger‐Bernays W, Hu XC, et al. PFAS exposure pathways for humans and wildlife: a synthesis of current knowledge and key gaps in understanding. Environ Toxicol Chem. 2021;40:631–57.
Sunderland EM, Hu XC, Dassuncao C, Tokranov AK, Wagner CC, Allen JG. A review of the pathways of human exposure to poly-and perfluoroalkyl substances (PFASs) and present understanding of health effects. J Expo Sci Environ Epidemiol. 2019;29:131–47.
Calafat AM, Wong LY, Kuklenyik Z, Reidy JA, Needham LL. Polyfluoroalkyl chemicals in the US population: data from the National Health and Nutrition Examination Survey (NHANES) 2003–2004 and comparisons with NHANES 1999–2000. Environ Health Perspect. 2007a;115:1596–602.
U.S. CDC (2022). “Biomonitoring Data Tables for Environmental Chemicals” https://www.cdc.gov/exposurereport/data_tables.html (accessed May 2022).
Stubleski J, Salihovic S, Lind L, Lind PM, van Bavel B, Kärrman A. Changes in serum levels of perfluoroalkyl substances during a 10-year follow-up period in a large population-based cohort. Environ Int. 2016;95:86–92.
Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Tully JS, Needham LL. Serum concentrations of 11 polyfluoroalkyl compounds in the US population: data from the National Health and Nutrition Examination Survey (NHANES) 1999−2000. Environ Sci Technol. 2007b;41:2237–42.
Herzke D, Olsson E, Posner S. Perfluoroalkyl and polyfluoroalkyl substances (PFASs) in consumer products in Norway–A pilot study. Chemosphere. 2012;88:980–7.
Buekers J, Colles A, Cornelis C, Morrens B, Govarts E, Schoeters G. Socio-economic status and health: evaluation of human biomonitored chemical exposure to per-and polyfluorinated substances across status. Int J Environ Res public health. 2018;15:2818.
Nelson JW, Scammell MK, Hatch EE, Webster TF. Social disparities in exposures to bisphenol A and polyfluoroalkyl chemicals: a cross-sectional study within NHANES 2003-2006. Environ Health. 2012;11:1–15.
Tyrrell J, Melzer D, Henley W, Galloway TS, Osborne NJ. Associations between socioeconomic status and environmental toxicant concentrations in adults in the USA: NHANES 2001–2010. Environ Int. 2013;59:328–35.
Harris MH, Rifas-Shiman SL, Calafat AM, Ye X, Mora AM, Webster TF, et al. Predictors of per-and polyfluoroalkyl substance (PFAS) plasma concentrations in 6–10 year old American children. Environ Sci Technol. 2017;51:5193–204.
Eick SM, Enright EA, Geiger SD, Dzwilewski KL, DeMicco E, Smith S, et al. Associations of maternal stress, prenatal exposure to per-and polyfluoroalkyl substances (PFAS), and demographic risk factors with birth outcomes and offspring neurodevelopment: an overview of the ECHO. CA. IL prospective birth cohorts. Int J Environ Res Public Health. 2021;18:742.
Chang CJ, Ryan PB, Smarr MM, Kannan K, Panuwet P, Dunlop AL, et al. Serum per-and polyfluoroalkyl substance (PFAS) concentrations and predictors of exposure among pregnant African American women in the Atlanta area, Georgia. Environ Res. 2021;198:110445.
Kato K, Wong LY, Jia LT, Kuklenyik Z, Calafat AM. Trends in exposure to polyfluoroalkyl chemicals in the US population: 1999−2008. Environ Sci Technol. 2011;45:8037–45.
Kingsley SL, Eliot MN, Kelsey KT, Calafat AM, Ehrlich S, Lanphear BP, et al. Variability and predictors of serum perfluoroalkyl substance concentrations during pregnancy and early childhood. Environ Res. 2018;165:247–57. https://doi.org/10.1016/j.envres.2018.04.033.
Kato K, Wong LY, Chen A, Dunbar C, Webster GM, Lanphear BP, et al. Changes in serum concentrations of maternal poly-and perfluoroalkyl substances over the course of pregnancy and predictors of exposure in a multiethnic cohort of Cincinnati, Ohio pregnant women during 2003–2006. Environ Sci Technol. 2014;48:9600–8.
Park SK, Peng Q, Ding N, Mukherjee B, Harlow SD. Determinants of per- and polyfluoroalkyl substances (PFAS) in midlife women: evidence of racial/ethnic and geographic differences in PFAS exposure. Environ Res. 2019;175:186–99. https://doi.org/10.1016/j.envres.2019.05.028.
Boronow KE, Brody JG, Schaider LA, Peaslee GF, Havas L, Cohn BA. Serum concentrations of PFASs and exposure-related behaviors in African American and non-Hispanic white women. J Expo Sci Environ Epidemiol. 2019;29:206–17. https://doi.org/10.1038/s41370-018-0109-y.
Ding N, Harlow SD, Batterman S, Mukherjee B, Park SK. Longitudinal trends in perfluoroalkyl and polyfluoroalkyl substances among multiethnic midlife women from 1999 to 2011: The Study of Women’s Health Across the Nation. Environ Int. 2020;135:105381. https://doi.org/10.1016/j.envint.2019.105381.
Olsen GW, Church TR, Hansen KJ, Burris JM, Butenhoff JL, Mandel JH, et al. Quantitative evaluation of perfluorooctanesulfonate (PFOS) and other fluorochemicals in the serum of children. J Children’s Health. 2004;2:53–76.
Kubwabo C, Stewart B, Zhu J, Marro L. Occurrence of perfluorosulfonates and other perfluorochemicals in dust from selected homes in the city of Ottawa, Canada. J Environ Monit. 2005;7:1074–8.
Karásková P, Venier M, Melymuk L, Bečanová J, Vojta Š, Prokeš R, et al. Perfluorinated alkyl substances (PFASs) in household dust in Central Europe and North America. Environ Int. 2016;94:315–24.
Knobeloch L, Imm P, Anderson H. Perfluoroalkyl chemicals in vacuum cleaner dust from 39 Wisconsin homes. Chemosphere. 2012;88:779–83.
Haug LS, Huber S, Schlabach M, Becher G, Thomsen C. Investigation on per-and polyfluorinated compounds in paired samples of house dust and indoor air from Norwegian homes. Environ Sci Technol. 2011;45:7991–8.
Moran RE, Bennett DH, Tancredi DJ, Ritz B, Hertz-Picciotto I. Frequency and longitudinal trends of household care product use. Atmos Environ. 2012;55:417–24.
Hu XC, Tokranov AK, Liddie J, Zhang X, Grandjean P, Hart JE, et al. Tap water contributions to plasma concentrations of poly-and perfluoroalkyl substances (PFAS) in a nationwide prospective cohort of US women. Environ Health Perspect. 2019;127:067006.
Chow SJ, Ojeda N, Jacangelo JG, Schwab KJ. Detection of ultrashort-chain and other per-and polyfluoroalkyl substances (PFAS) in US bottled water. Water Res. 2021;201:117292.
Tian Y, Zhou Y, Miao M, Wang Z, Yuan W, Liu X, et al. Determinants of plasma concentrations of perfluoroalkyl and polyfluoroalkyl substances in pregnant women from a birth cohort in Shanghai, China. Environ Int. 2018;119:165–73.
Nelson JW, Hatch EE, Webster TF. Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general US population. Environ Health Perspect. 2010;118:197–202.
Susmann HP, Schaider LA, Rodgers KM, Rudel RA. Dietary habits related to food packaging and population exposure to PFASs. Environ Health Perspect. 2019;127:107003.
Schaider LA, Balan SA, Blum A, Andrews DQ, Strynar MJ, Dickinson ME, et al. Fluorinated compounds in US fast food packaging. Environ Sci Technol Lett. 2017;4:105–11.
Sagiv SK, Rifas-Shiman SL, Webster TF, Mora AM, Harris MH, Calafat AM, et al. Sociodemographic and perinatal predictors of early pregnancy per- and polyfluoroalkyl substance (PFAS) concentrations. Environ Sci Technol. 2015;49:11849–58. https://doi.org/10.1021/acs.est.5b02489.
Shu H, Lindh CH, Wikström S, Bornehag CG. Temporal trends and predictors of perfluoroalkyl substances serum levels in Swedish pregnant women in the SELMA study. PLoS One. 2018;13:e0209255.
Preston EV, Webster TF, Claus Henn B, McClean MD, Gennings C, Oken E, et al. Prenatal exposure to per- and polyfluoroalkyl substances and maternal and neonatal thyroid function in the Project Viva Cohort: a mixtures approach. Environ Int. 2020;139:105728. https://doi.org/10.1016/j.envint.2020.105728.
Berg V, Nøst TH, Huber S, Rylander C, Hansen S, Veyhe AS, et al. Maternal serum concentrations of per-and polyfluoroalkyl substances and their predictors in years with reduced production and use. Environ Int. 2014;69:58–66.
U.S. Government Accountability Office (2022). “Persistent Chemicals: EPA Should Use New Data to Analyze the Demographics of Communities with PFAS in their Drinking Water”. https://www.gao.gov/assets/gao-22-105135.pdf (accessed November 2022).
U.S. Department of Health and Human Services National Institutes of Health (2022). “Data and Specimen Hub (DASH)”. https://dash.nichd.nih.gov/ (accessed February 2020–2022).
Landrigan PJ, Trasande L, Thorpe LE, Gwynn C, Lioy PJ, D’Alton ME, et al. The National Children’s Study: a 21-year prospective study of 100,000 American children. Pediatrics. 2006;118:2173–86.
Hirschfeld S, Songco D, Kramer BS, Guttmacher AE. National Children’s Study: update in 2010. Mount Sinai. J Med: A J Transl Personal Med. 2011;78:119–25.
Montaquila JM, Brick JM, Curtin LR. Statistical and practical issues in the design of a national probability sample of births for the Vanguard Study of the National Children’s Study. Stat Med. 2010;29:1368–76.
Mortensen ME, Hirschfeld S. The National Children’s Study: an opportunity for medical toxicology. J Med Toxicol. 2012;8:160–5.
Baker D, Park C, Sweeney C, McCormack L, Durkin M, Brenner R, et al. Recruitment of women in the National Children’s Study initial Vanguard Study. Am J Epidemiol. 2014;179:1366–74.
Stanford JB, Brenner R, Fetterer D, Palmer L, Schoendorf KC. Impact of preconception enrollment on birth enrollment and timing of exposure assessment in the initial vanguard cohort of the US National Children’s Study. BMC Med Res Methodol. 2015;15:1–11.
Gardener H, Sun Q, Grandjean P. PFAS concentration during pregnancy in relation to cardiometabolic health and birth outcomes. Environ Res. 2021;192:110287.
留言 (0)